Crowther, C.Hiller, J.Haslam, R.Robinson, J.2006-06-222006-06-221997Pediatrics, 1997; 99(3):311-3170031-40051098-4275http://hdl.handle.net/2440/4244Reports a 12-month follow up of the health and development of the children entered into the Australian Collaborative Trial of Antenatal Thyrotropin-Releasing Hormone (ACTOBAT). Long term adverse effect of Thyrotropin-Releasing Hormone (TRH); Milestone differences detected between comparison groups and those not exposed to TRH in utero.enCopyright © 1997 by the American Academy of PediatricsHumansRespiratory Distress Syndrome, NewbornGlucocorticoidsDrug Therapy, CombinationPrenatal CareInfant MortalityLogistic ModelsFollow-Up StudiesDevelopmental DisabilitiesPregnancyAdultInfant, NewbornFemaleObstetric Labor, PrematureMaleThyrotropin-Releasing HormoneAustralian collaborative trial of antenatal thyrotropin-releasing hormone: adverse effects at 12-month follow-upJournal article0030006375001997258510.1542/peds.99.3.311A1997WR147000012-s2.0-003097569570381Crowther, C. [0000-0002-9079-4451]Hiller, J. [0000-0002-8532-4033]Robinson, J. [0000-0002-4515-6039]